Precision BioSciences Reports Major Q4 Losses

Precision BioSciences faces significant losses in Q4. With earnings dropping to -$2.22 per share and revenue plummeting by 90.9%, investor sentiment may take a downturn.

Date: 26-03-2025

AI Rating: 4

Company Performance Overview: Precision BioSciences Inc (DTIL) reported a loss for the fourth quarter amounting to -$17.75 million, equivalent to -$2.22 per share. This is a deterioration compared to the previous year's loss of -$16.29 million, or -$4.06 per share.

Revenue Analysis: The company experienced a staggering revenue decline of 90.9%, from $7.04 million last year to just $0.64 million this year. This sharp decrease raises concerns regarding the company's operational efficiency and market demand.

Earnings Per Share (EPS): The reported EPS of -$2.22 shows further losses, albeit an improvement from last year’s -$4.06. While the reduction in the EPS loss is a minor positive sign, the company is still incurring considerable losses.

Stocks: DTIL